Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Japanese (NIKKEI) Biotech Industry Analysis

UpdatedAug 16, 2026
DataAggregated Company Financials
Companies34
  • 7D7.0%
  • 3M-9.2%
  • 1Y-25.1%
  • YTD-7.8%

Oncolys BioPharma is up 14%, leading the way for the Biotech industry, which has gained 7.0%. In contrast, the industry has lost 25% in the last 12 months. Earnings are forecast to grow by 35% annually.

Industry Valuation and Performance

Has the Japanese Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 16 Aug 2026JP¥929.0bJP¥159.5b-JP¥43,744,461,682.0029.6x-21.2x5.8x
Tue, 14 Jul 2026JP¥841.7bJP¥159.3b-JP¥44,566,762,682.0029.1x-18.9x5.3x
Thu, 11 Jun 2026JP¥964.4bJP¥198.8b-JP¥57,269,138,682.0047x-16.8x4.9x
Sat, 09 May 2026JP¥1.2tJP¥202.7b-JP¥49,543,646,682.0061.1x-23.3x5.7x
Mon, 06 Apr 2026JP¥1.1tJP¥202.7b-JP¥49,292,644,682.0056.5x-22.9x5.6x
Wed, 04 Mar 2026JP¥1.2tJP¥200.5b-JP¥50,373,794,682.00316x-24.3x6.1x
Fri, 30 Jan 2026JP¥1.1tJP¥198.7b-JP¥70,406,297,000.0059.8x-15.2x5.4x
Sun, 28 Dec 2025JP¥978.7bJP¥198.7b-JP¥70,727,387,000.0052.7x-13.8x4.9x
Tue, 25 Nov 2025JP¥1.1tJP¥196.3b-JP¥69,252,365,000.0052.3x-15.2x5.4x
Thu, 23 Oct 2025JP¥1.2tJP¥197.7b-JP¥65,502,224,000.0065x-17.6x5.8x
Sat, 20 Sep 2025JP¥1.2tJP¥197.7b-JP¥65,794,561,000.0064.6x-18.3x6.1x
Mon, 18 Aug 2025JP¥1.2tJP¥193.5b-JP¥68,256,278,000.00119.2x-17.6x6.2x
Wed, 16 Jul 2025JP¥1.1tJP¥218.2b-JP¥43,671,220,000.00100.2x-25x5x
Fri, 13 Jun 2025JP¥1.2tJP¥216.3b-JP¥42,942,705,000.0091.4x-28.7x5.7x
Sun, 11 May 2025JP¥1.1tJP¥207.8b-JP¥38,747,850,000.0014.6x-27.4x5.1x
Tue, 08 Apr 2025JP¥816.2bJP¥207.7b-JP¥39,165,298,000.0012.6x-20.8x3.9x
Thu, 06 Mar 2025JP¥987.8bJP¥207.4b-JP¥38,725,942,000.0015.5x-25.5x4.8x
Sat, 01 Feb 2025JP¥996.2bJP¥207.3b-JP¥13,514,452,000.0020.7x-73.7x4.8x
Mon, 30 Dec 2024JP¥1.1tJP¥206.4b-JP¥12,718,356,000.0022.2x-85.2x5.2x
Wed, 27 Nov 2024JP¥1.1tJP¥207.2b-JP¥11,247,446,000.0021.5x-96x5.2x
Fri, 25 Oct 2024JP¥1.1tJP¥214.3b-JP¥3,941,502,000.0020.7x-269.2x5x
Sun, 22 Sep 2024JP¥1.1tJP¥214.3b-JP¥2,078,229,000.0020.2x-542.4x5.3x
Tue, 20 Aug 2024JP¥1.0tJP¥209.7b-JP¥703,432,000.0014.1x-1466.2x4.9x
Thu, 18 Jul 2024JP¥1.1tJP¥187.7b-JP¥15,872,047,000.0095.7x-70.3x5.9x
Sat, 15 Jun 2024JP¥909.1bJP¥193.8b-JP¥15,007,284,000.0099.3x-60.6x4.7x
Mon, 13 May 2024JP¥796.4bJP¥195.0b-JP¥13,546,545,000.0083.4x-58.8x4.1x
Wed, 10 Apr 2024JP¥771.2bJP¥194.2b-JP¥15,457,837,000.0065.8x-49.9x4x
Fri, 08 Mar 2024JP¥804.9bJP¥196.2b-JP¥19,179,997,000.0060.7x-42x4.1x
Sun, 04 Feb 2024JP¥744.0bJP¥222.4b-JP¥12,442,827,000.0017.5x-59.8x3.3x
Tue, 02 Jan 2024JP¥814.6bJP¥222.3b-JP¥12,668,455,000.0017.6x-64.3x3.7x
Thu, 30 Nov 2023JP¥804.9bJP¥221.9b-JP¥12,426,487,000.0016.9x-64.8x3.6x
Sat, 28 Oct 2023JP¥718.5bJP¥223.0b-JP¥14,478,735,000.0018x-49.6x3.2x
Mon, 25 Sep 2023JP¥852.4bJP¥223.0b-JP¥14,518,735,000.0027.5x-58.7x3.8x
Wed, 23 Aug 2023JP¥875.6bJP¥225.1b-JP¥19,814,131,000.0048.7x-44.2x3.9x
Price to Earnings Ratio

-44.2x


Total Market Cap: JP¥875.6bTotal Earnings: -JP¥19,814,131,000.00Total Revenue: JP¥225.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Japanese Biotech Industry Price to Earnings3Y Average -113x202420252026
Current Industry PE
  • Investors are optimistic on the Japanese Biotechs industry, and appear confident in long term growth rates.
  • The 3-year average PS ratio of 4.9x is lower than the industry's current PS ratio of 5.8x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have deteriorated over the last three years.
  • Revenues have also declined 11% per year.
  • This means overall sales from these companies are declining and losses are subsequently expanding as well.

Industry Trends

Which industries have driven the changes within the Japanese Healthcare industry?

JP Market2.94%
Healthcare2.21%
Biotech7.00%
Biotech7.00%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
4588 Oncolys BioPharmaJP¥3.25k14.1%
+JP¥11.8b		356.5%PS3335.2x
2160 GNI GroupJP¥2.94k5.7%
+JP¥10.4b		-1.6%PS7.3x
4587 PeptiDreamJP¥1.03k4.6%
+JP¥5.9b		-36.7%PS6.9x
7777 3-D MatrixJP¥371.0010.1%
+JP¥4.4b		49.6%PE11.4x
4592 SanBioJP¥1.04k5.1%
+JP¥4.0b		-61.3%PB6.4x

Latest News

2160
JP¥2,935.00
GNI Group
7D
5.7%
1Y
-1.6%
4587
JP¥1,031.50
PeptiDream
7D
4.6%
1Y
-36.7%
Analysis Article • Aug 14

The PeptiDream Inc. (TSE:4587) Half-Yearly Results Are Out And Analysts Have Published New Forecasts

PeptiDream Inc. ( TSE:4587 ) just released its latest half-yearly report and things are not looking great. It was not a...
4593
JP¥272.00
Healios K.K
7D
10.1%
1Y
-54.7%
4592
JP¥1,043.00
SanBio
7D
5.1%
1Y
-61.3%
4894
JP¥5,400.00
Cuorips
7D
7.8%
1Y
-20.6%
4598
JP¥106.00
Delta-Fly Pharma
7D
-0.9%
1Y
-83.5%
219A
JP¥1,940.00
Heartseed
7D
7.1%
1Y
-47.5%
177A
JP¥875.00
Kohjin Bio
7D
-0.6%
1Y
-48.5%
7777
JP¥371.00
3-D Matrix
7D
10.1%
1Y
49.6%
Analysis Article • Jun 18

3-D Matrix's (TSE:7777) Performance Raises Some Questions

Strong earnings weren't enough to please 3-D Matrix, Ltd.'s ( TSE:7777 ) shareholders over the last week. Our analysis...
4588
JP¥3,250.00
Oncolys BioPharma
7D
14.1%
1Y
356.5%